[Practical problems of the use of cardiac glycosides]. 1978

V G Naumov, and T D Tsibekmakher, and V Iu Mareev

UI MeSH Term Description Entries
D002318 Cardiovascular Diseases Pathological conditions involving the CARDIOVASCULAR SYSTEM including the HEART; the BLOOD VESSELS; or the PERICARDIUM. Adverse Cardiac Event,Cardiac Events,Major Adverse Cardiac Events,Adverse Cardiac Events,Cardiac Event,Cardiac Event, Adverse,Cardiac Events, Adverse,Cardiovascular Disease,Disease, Cardiovascular,Event, Cardiac
D004074 Digitoxin A cardiac glycoside sometimes used in place of DIGOXIN. It has a longer half-life than digoxin; toxic effects, which are similar to those of digoxin, are longer lasting. (From Martindale, The Extra Pharmacopoeia, 30th ed, p665) Coramedan,Digimed,Digimerck,Digitaline Nativelle,Digitoxin AWD,Digitoxin Bürger,Digitoxin Didier,Digitoxin-Philo,Digophton,AWD, Digitoxin,Bürger, Digitoxin,Didier, Digitoxin,Digitoxin Philo,Nativelle, Digitaline
D004077 Digoxin A cardiotonic glycoside obtained mainly from Digitalis lanata; it consists of three sugars and the aglycone DIGOXIGENIN. Digoxin has positive inotropic and negative chronotropic activity. It is used to control ventricular rate in ATRIAL FIBRILLATION and in the management of congestive heart failure with atrial fibrillation. Its use in congestive heart failure and sinus rhythm is less certain. The margin between toxic and therapeutic doses is small. (From Martindale, The Extra Pharmacopoeia, 30th ed, p666) Digacin,Digitek,Digoregen,Digoxina Boehringer,Digoxine Nativelle,Dilanacin,Hemigoxine Nativelle,Lanacordin,Lanicor,Lanoxicaps,Lanoxin,Lanoxin-PG,Lenoxin,Mapluxin,Boehringer, Digoxina,Lanoxin PG,Nativelle, Digoxine,Nativelle, Hemigoxine
D004341 Drug Evaluation Any process by which toxicity, metabolism, absorption, elimination, preferred route of administration, safe dosage range, etc., for a drug or group of drugs is determined through clinical assessment in humans or veterinary animals. Evaluation Studies, Drug,Drug Evaluation Studies,Drug Evaluation Study,Drug Evaluations,Evaluation Study, Drug,Evaluation, Drug,Evaluations, Drug,Studies, Drug Evaluation,Study, Drug Evaluation
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013328 Strophanthins A number of different cardioactive glycosides obtained from Strophanthus species. OUABAIN is from S. gratus and CYMARINE from S. kombe. They are used like the digitalis glycosides. Strophanthin

Related Publications

V G Naumov, and T D Tsibekmakher, and V Iu Mareev
September 1976, Voenno-meditsinskii zhurnal,
V G Naumov, and T D Tsibekmakher, and V Iu Mareev
April 1969, Kardiologiia,
V G Naumov, and T D Tsibekmakher, and V Iu Mareev
September 1977, Kardiologiia,
V G Naumov, and T D Tsibekmakher, and V Iu Mareev
August 1975, Zeitschrift fur die gesamte innere Medizin und ihre Grenzgebiete,
V G Naumov, and T D Tsibekmakher, and V Iu Mareev
December 1973, Nederlands tijdschrift voor geneeskunde,
V G Naumov, and T D Tsibekmakher, and V Iu Mareev
March 1959, Die Medizinische,
V G Naumov, and T D Tsibekmakher, and V Iu Mareev
February 1964, Hippokrates,
V G Naumov, and T D Tsibekmakher, and V Iu Mareev
December 1970, Zeitschrift fur praktische Anasthesie und Wiederbelebung,
V G Naumov, and T D Tsibekmakher, and V Iu Mareev
October 1967, Zahnarztliche Praxis,
V G Naumov, and T D Tsibekmakher, and V Iu Mareev
May 1977, Voprosy okhrany materinstva i detstva,
Copied contents to your clipboard!